Kayla M. Teopiz, HBSc
a:2:{i:0;s:66:"Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada";i:1;s:77:"Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada";}
Original Research
Global Population-Based Study on the Association Between Ketamine and Esketamine with Suicidality Using WHO VigiBase
July 7, 2025
The results do not provide causal evidence of worsening suicidality in persons receiving esketamine/ketamine; mixed results of increased and decreased risk of suicidality were reported with both agents.
